KP
Kalvista Pharmaceuticals Inc
🇩🇪XFRA.4XC1GermanyHealthcare
€22.73EURunchanged 0.00 (0%)ClosedEnd of day1:26 AM
Price€22.730.00 (0%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US4834971032
- CUSIP
- Not reported
Company
- Employees
- 275
- Headquarters
- Framingham, United States
- Website
- https://www.kalvista.com
- CEO
- Mr. Benjamin L. Palleiko
Market
- Shares outstanding
- 50.5M
- Market cap
- €1.15B
Highlights
No high and low reported for today's session.
- Market cap
- €1.15B
- EPS LTM
- -$2.22calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $143.08M+100%up year on year
- Net income
- -$112.44M+38.71%up year on year
- Gross margin
- 92.24%
- Free cash flow
- -$38.51M+74.8%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.